If you are in Newport Beach and have been questioning if insurance covers semaglutide or other weight loss meds, Klinic takes the guesswork out
Circulatory stagnation reduces
(2025) Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
Lancet Diabetes Endocrinol 7(7):549559 Mok J et al (2023) Safety and efficacy of liraglutide, 3.0 mg, once daily vs placebo in patients with poor weight loss following metabolic surgery: the BARI-OPTIMISE randomized clinical trial
For the beneficiary to qualify, a provider must submit a prior authorization request to the program that attests the beneficiary is prescribed the requested drug to reduce excess body weight and maintain weight reduction in combination with current and ongoing lifestyle modification including structured nutrition and physical activity consistent with the applicable FDA approved label, and the beneficiary is at least 18 years of age with a BMI greater than or equal to 35. For beneficiaries with underlying medical conditions, the BMI threshold is lowered to 30 or 25 based on the diagnosis
The document summarizes the evidence behind using GLP-1s for weight loss independent of diabetes management
